Option Care Health Inc (OPCH) Stock Analysis

Verdict: WATCH (do not buy)

Pending $32.05 cash takeover by CD&R/McKesson caps upside at 2.8% — rendering OPCH an arbitrage hold with downside risk if deal fails.

Investment score: 53/100

Analysis as of

Is Option Care Health Inc stock worth reviewing? AI model thesis

OPCH is trading near its definitive $32.05 per share cash buyout price, limiting 90-day capital gain potential to 2.8% and creating an asymmetric downside risk profile if regulatory obstacles emerge.

7-factor investment score

Option Care Health Inc opportunities and risks

What speaks for OPCH

What speaks against OPCH

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
OPCH23.5x0.8x13.8x18.2%3.7%7.4%
RDNTn/a2.4x25.0x9.7%-0.9%-1.1%
LFST95.4x3.0x35.9x33.6%3.2%4.4%
BLLN147.5x12.1x87.6x71.3%8.4%0.7%
CRVL35.9x4.1x20.9x23.9%11.7%2.8%
PRVA100.7x1.2xn/a7.6%1.2%-1.7%
Peer median95.4x3.0x25.0x23.9%3.2%0.7%

Frequently asked questions about Option Care Health Inc (OPCH)

Is OPCH stock a good investment?

The cached TradeMates AI model rates Option Care Health Inc as WATCH (do not buy) with an investment score of 53/100. OPCH is trading near its definitive $32.05 per share cash buyout price, limiting 90-day capital gain potential to 2.8% and creating an asymmetric downside risk profile if regulatory obstacles emerge. This is algorithmic model output, not personal investment advice.

Is OPCH stock a buy?

The TradeMates model verdict for OPCH is WATCH (do not buy) with an investment score of 53/100. Treat this as a model signal to review, not a personal buy recommendation.